Michael Babich, who resigned as the Arizona-based drugmaker’s CEO in 2015 and was slated to face trial next month, has agreed to plead guilty to conspiracy and mail fraud charges, federal prosecutors in Boston disclosed in a court filing.
Former Insys CEO to Plead Guilty to Opioid Kickback Scheme
The former chief executive of Insys Therapeutics Inc has agreed to plead guilty to participating in a scheme to bribe doctors to prescribe a powerful opioid medication sold by the company, U.S. prosecutors said on Wednesday.
Source: Reuters | Published on December 27, 2018
Are you a retail Agent Looking for a Quote?